- Home
- ZVRA vs FHTX Comparison
ZVRA vs FHTX Comparison
Compare ZVRA & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVRA
- FHTX
- Stock Information
- Founded
- ZVRA 2006
- FHTX 2015
- Country
- ZVRA United States
- FHTX United States
- Employees
- ZVRA N/A
- FHTX N/A
- Industry
- ZVRA Biotechnology: Pharmaceutical Preparations
- FHTX Medicinal Chemicals and Botanical Products
- Sector
- ZVRA Health Care
- FHTX Health Care
- Exchange
- ZVRA Nasdaq
- FHTX Nasdaq
- Market Cap
- ZVRA 400.8M
- FHTX N/A
- IPO Year
- ZVRA 2015
- FHTX 2020
- Fundamental
- Price
- ZVRA $8.93
- FHTX $4.89
- Analyst Decision
- ZVRA Strong Buy
- FHTX Strong Buy
- Analyst Count
- ZVRA 8
- FHTX 8
- Target Price
- ZVRA $22.29
- FHTX $12.63
- AVG Volume (30 Days)
- ZVRA 577.3K
- FHTX 141.1K
- Earning Date
- ZVRA 08-12-2025
- FHTX 08-07-2025
- Dividend Yield
- ZVRA N/A
- FHTX N/A
- EPS Growth
- ZVRA N/A
- FHTX N/A
- EPS
- ZVRA N/A
- FHTX N/A
- Revenue
- ZVRA $40,588,000.00
- FHTX $23,504,000.00
- Revenue This Year
- ZVRA $292.31
- FHTX $44.01
- Revenue Next Year
- ZVRA $78.65
- FHTX $9.45
- P/E Ratio
- ZVRA N/A
- FHTX N/A
- Revenue Growth
- ZVRA 46.47
- FHTX N/A
- 52 Week Low
- ZVRA $4.20
- FHTX $2.95
- 52 Week High
- ZVRA $9.76
- FHTX $10.25
- Technical
- Relative Strength Index (RSI)
- ZVRA 54.24
- FHTX 61.01
- Support Level
- ZVRA $8.89
- FHTX $4.65
- Resistance Level
- ZVRA $9.43
- FHTX $5.09
- Average True Range (ATR)
- ZVRA 0.30
- FHTX 0.32
- MACD
- ZVRA -0.05
- FHTX 0.03
- Stochastic Oscillator
- ZVRA 36.81
- FHTX 72.94
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.